As a leading innovation-driven corporation, Hetero is developing a growing portfolio of pharmaceutical products to meet some of the world's most urgent medical needs. Today Hetero is manufacturing product portfolio of over 200 products in major therapeutic areas, with an emphasis on antiretroviral, gastro-intestinal, cardiovascular, antidepressants/antipsychotics, antidiabetics, pain management, anti-infectives, dermatology and oncology. Hetero has
- Four finished dosage manufacturing facilities, out of which two are USFDA approved facilities.
- Dedicated Oncology facility
- Offers
- Injectables
- Solid/Liquid oral dosages
- Ointments
- Soft gelatine capsules
- Inhalers
